Leaderboards/Inflammatory Myopathies and Dermatomyositis

Inflammatory Myopathies and Dermatomyositis

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Sarah E. Chang
University of Michigan
2
Tracy Tabib
University of Pittsburgh
3
Ann‐Christin Pecher
Center for Rheumatology
4
María Casal-Domínguez
National Institutes of Health
5
Xianhua Gui
Nanjing Drum Tower Hospital
6
Caoilfhionn M Connolly
Johns Hopkins University
7
Tom Aschman
Charité - Universitätsmedizin Berlin
8
Jule Taubmann
Universitätsklinikum Erlangen
9
Kyla A. Britson
Public Health Dayton & Montgomery County
10
Jacqueline So
Chinese University of Hong Kong

Rising Stars Papers

1
Idiopathic inflammatory myopathies: current insights and future frontiers
The Lancet Rheumatology|2024
61 cit.
2
CD19-targeting CAR T cell therapy in five patients with systemic sclerosis unsuitable for autologous stem cell transplantation
EULAR Rheumatology Open|2025
11 cit.
3
Ovarian reserve alteration in premenopausal women with systemic sclerosis
Rheumatology International|2024
9 cit.
4
Pretreatment mortality risk prediction model in patients with polymyositis/dermatomyositis-associated interstitial lung disease
RMD Open|2024
7 cit.
5
Langzeitverlauf von Effizienz und Sicherheit der CD19-CAR T-Zell-Therapie beim systemischen Lupus erythematodes
Zeitschrift für Rheumatologie|2025
5 cit.
6
Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome
Arthritis Research & Therapy|2024
4 cit.
7
Evaluation of oral health in 148 patients with systemic sclerosis—data from a prospective interdisciplinary monocentric cohort
Rheumatology International|2024
4 cit.
8
Pursuing Clinical Predictors and Biomarkers for Progression in ILD: Analysis of the Pulmonary Fibrosis Foundation (PFF) Registry
Lung|2024
3 cit.
9
Altered IgG4 serum levels in VEXAS syndrome – a retrospective monocentric cohort study
Rheumatology International|2025
2 cit.
10
Chlamydia psittaci infection-associated acute fibrinous and organizing pneumonitis: A case report
IDCases|2025
1 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Yves Allenbach
Sorbonne Université
2
Werner Stenzelr
Charité - Universitätsmedizin Berlin
3
Sarah Tansley
Royal National Hospital for Rheumatic Diseases
4
Marie Holmqvist
Karolinska University Hospital
5
Xiaoming Shu
China-Japan Friendship Hospital
6
Qinglin Peng
China-Japan Friendship Hospital
7
Todd Levine
Phoenix Neurological Associates
8
Jing He
Gansu University of Traditional Chinese Medicine
9
Ayumi Yoshizaki
University of Tokyo Hospital
10
Jemima Albayda
Johns Hopkins University

Emerging Leaders Papers

1
Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis
Science Advances|2022
222 cit.
2
Trial of Intravenous Immune Globulin in Dermatomyositis
New England Journal of Medicine|2022
206 cit.
3
Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis
Cancer Discovery|2023
202 cit.
4
Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome
Frontiers in Immunology|2022
89 cit.
5
Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome
JAMA Network Open|2022
88 cit.
6
Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti‐MDA5‐positive dermatomyositis
Journal of Internal Medicine|2023
61 cit.
7
Dilemma of immunosuppression and infection risk in systemic lupus erythematosus
Lara D. Veeken|2023
50 cit.
8
A double‐blind placebo‐controlled pilot study of immunoglobulin for small fiber neuropathy associated with <scp>TS‐HDS</scp> and <scp>FGFR</scp>‐3 autoantibodies
Muscle & Nerve|2022
40 cit.
9
Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array
Frontiers in Immunology|2023
37 cit.
10
Synuclein-One Study: Skin Biopsy Detection of Phosphorylated α-Synuclein for Diagnosis of Synucleinopathies
Biomarkers in Medicine|2022
33 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Lisa G. Rider
National Cancer Institute
2
Frederick W. Miller
National Institute of Environmental Health Sciences
3
Andrew G. Engel
Thomas Jefferson University
4
Ingrid E. Lundberg
Karolinska University Hospital
5
Andrew L. Mammen
Malaysian Society of Nephrology
6
Ichizo Nishino
National Center of Neurology and Psychiatry
7
Lauren M. Pachman
Northwestern University
8
Marinos C. Dalakas
National and Kapodistrian University of Athens
9
Thomas A. Medsger
University of Pittsburgh
10
Olivier Benvéniste
Inserm

Current Senior Leaders Papers

1
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
Annals of the Rheumatic Diseases|2017
1.5k cit.
2
Changes in causes of death in systemic sclerosis, 1972–2002
Annals of the Rheumatic Diseases|2007
1.5k cit.
3
Criteria for the classification of early systemic sclerosis.
PubMed|2001
1.4k cit.
4
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
New England Journal of Medicine|1993
1.1k cit.
5
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
Medicine|1991
973 cit.
6
Polymyositis, Dermatomyositis, and Inclusion-Body Myositis
New England Journal of Medicine|1991
944 cit.
7
Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
Nature|2000
942 cit.
8
Birth Defects Original Article Series
Neurology|1970
902 cit.
9
Thymidine Phosphorylase Gene Mutations in MNGIE, a Human Mitochondrial Disorder
Science|1999
900 cit.
10
Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy
New England Journal of Medicine|1990
848 cit.

Reagents for Inflammatory Myopathies and Dermatomyositis

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

SignalStain® Aqueous Mounting Medium

#27290$223
View Evidence →

⭐ Top Rated

Best all-around

Cell Signaling Technology

Phospho-Ubiquitin (Ser65) (E2J6T) Rabbit Monoclonal Antibody

#62802$2,221,157
View Evidence →
Cell Signaling TechnologyEvidence 65

Acetyl-alpha-Tubulin (Lys40) (D20G3) Rabbit Monoclonal Antibody (HRP Conjugate)

#14652$493
View Evidence →
Cell Signaling Technology

Phospho-Drosophila p70 S6 Kinase (Thr398) Antibody

#9209$366
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

COMT (D4N6M) Rabbit Monoclonal Antibody

#14368$161,351
View Evidence →
Agilent/DakoEvidence 69

CD4

#M7310
View Evidence →
Cell Signaling TechnologyEvidence 63

TRIM33 (D7U4F) Rabbit Monoclonal Antibody

#90051$161,351
View Evidence →